Allarity Therapeutics, Inc.
ALLR · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $23,289 | $15,699 | $1,044 | $1,844 |
| - Cash | $16,895 | $17,801 | $25,201 | $19,533 |
| + Debt | $0 | $1,375 | $1,363 | $1,350 |
| Enterprise Value | $6,394 | -$727 | -$22,794 | -$16,339 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$2,749 | -$2,296 | -$2,664 | -$7,377 |
| % Margin | – | – | – | – |
| Net Income | -$2,806 | -$2,320 | -$2,732 | -$7,453 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.19 | -0.149 | -0.245 | -1.021 |
| % Growth | -27.5% | 39.1% | 76% | – |
| Operating Cash Flow | -$3,410 | -$5,481 | -$2,686 | -$3,206 |
| Capital Expenditures | $0 | $0 | $0 | -$298 |
| Free Cash Flow | -$3,410 | -$5,481 | -$2,686 | -$3,504 |